JP2006528211A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528211A5 JP2006528211A5 JP2006529603A JP2006529603A JP2006528211A5 JP 2006528211 A5 JP2006528211 A5 JP 2006528211A5 JP 2006529603 A JP2006529603 A JP 2006529603A JP 2006529603 A JP2006529603 A JP 2006529603A JP 2006528211 A5 JP2006528211 A5 JP 2006528211A5
- Authority
- JP
- Japan
- Prior art keywords
- surfactant
- polydimethylsiloxane
- weight
- range
- proportion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000004094 surface-active agent Substances 0.000 claims description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 15
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 15
- -1 polydimethylsiloxane Polymers 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 7
- 239000003945 anionic surfactant Substances 0.000 claims description 6
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 5
- 239000010459 dolomite Substances 0.000 claims description 5
- 229910000514 dolomite Inorganic materials 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229910021536 Zeolite Inorganic materials 0.000 claims description 4
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 4
- 239000010457 zeolite Substances 0.000 claims description 4
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 230000001093 anti-cancer Effects 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000004035 construction material Substances 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910004283 SiO 4 Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10323758A DE10323758A1 (de) | 2003-05-22 | 2003-05-22 | Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen |
| PCT/DE2004/001048 WO2004105776A1 (de) | 2003-05-22 | 2004-05-19 | Heilmittel zur inneren anwendung; insbesondere gegen krebserkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006528211A JP2006528211A (ja) | 2006-12-14 |
| JP2006528211A5 true JP2006528211A5 (enExample) | 2007-07-05 |
Family
ID=33441299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006529603A Withdrawn JP2006528211A (ja) | 2003-05-22 | 2004-05-19 | 癌治療用の内服用の薬 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070172435A1 (enExample) |
| EP (1) | EP1635849A1 (enExample) |
| JP (1) | JP2006528211A (enExample) |
| CN (1) | CN1795001A (enExample) |
| AU (1) | AU2004243524A1 (enExample) |
| CA (1) | CA2526175A1 (enExample) |
| DE (1) | DE10323758A1 (enExample) |
| RU (1) | RU2005140097A (enExample) |
| WO (1) | WO2004105776A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10323759A1 (de) * | 2003-05-22 | 2004-12-16 | Bauer, Wulf, Dr. | Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen |
| BE1018537A3 (fr) | 2007-09-13 | 2011-03-01 | Basf Se | Procede d'exploitation d'une separation en continu d'un produit cible x sous la forme d'un cristallisat finement divise. |
| DE102007043748A1 (de) | 2007-09-13 | 2008-09-11 | Basf Se | Verfahren zur kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat |
| DE102007043758A1 (de) | 2007-09-13 | 2008-10-23 | Basf Se | Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat des Zielproduktes X |
| DE102007043759A1 (de) | 2007-09-13 | 2008-09-11 | Basf Se | Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat |
| DE102010030279A1 (de) | 2010-06-18 | 2010-10-28 | Basf Se | Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge |
| US8461383B2 (en) | 2009-10-16 | 2013-06-11 | Basf Se | Process for starting up a separating process for purifying removal of acrylic acid crystals from a suspension S of crystals thereof in mother liquor |
| DE102009045767A1 (de) | 2009-10-16 | 2010-08-12 | Basf Se | Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge |
| US10398727B2 (en) | 2014-11-24 | 2019-09-03 | University Of Technology, Sydney | Methods for the treatment and prevention of asbestos-related diseases |
| CN104606261B (zh) * | 2015-03-05 | 2018-02-09 | 潘友长 | 一种沸石药物组合物及其制备方法和用途 |
| CN105837734A (zh) * | 2016-05-09 | 2016-08-10 | 上海惠昌化工厂 | 有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
| US5418220A (en) * | 1994-03-08 | 1995-05-23 | Schmidt; Alfred | Method for treating constipation using dimethicone |
| US5587149A (en) * | 1995-02-06 | 1996-12-24 | R.P. Scherer Corporation | Topical application emulsions |
| DE59707063D1 (de) * | 1996-03-25 | 2002-05-23 | Bauer Wulf | Heilmittel zur äusserlichen anwendung und verwendung einer wässrigen öl-emulsion für ein derartiges heilmittel |
| US6347408B1 (en) * | 1998-11-05 | 2002-02-19 | Allegiance Corporation | Powder-free gloves having a coating containing cross-linked polyurethane and silicone and method of making the same |
| EP1107826A1 (de) * | 1999-04-26 | 2001-06-20 | Tihomir Lelas | Vorrichtung zum mikronisieren von materialien |
-
2003
- 2003-05-22 DE DE10323758A patent/DE10323758A1/de not_active Withdrawn
-
2004
- 2004-05-19 EP EP04733761A patent/EP1635849A1/de not_active Withdrawn
- 2004-05-19 RU RU2005140097/15A patent/RU2005140097A/ru unknown
- 2004-05-19 JP JP2006529603A patent/JP2006528211A/ja not_active Withdrawn
- 2004-05-19 WO PCT/DE2004/001048 patent/WO2004105776A1/de not_active Ceased
- 2004-05-19 US US10/557,317 patent/US20070172435A1/en not_active Abandoned
- 2004-05-19 CA CA002526175A patent/CA2526175A1/en not_active Abandoned
- 2004-05-19 CN CNA2004800140406A patent/CN1795001A/zh active Pending
- 2004-05-19 AU AU2004243524A patent/AU2004243524A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| López-Galindo et al. | Pharmaceutical and cosmetic applications of clays | |
| JP2006528211A5 (enExample) | ||
| Gomella et al. | Clinician's pocket drug reference | |
| Williams et al. | Kaolins and health: from first grade to first aid | |
| JPH03151005A (ja) | マルトデキストリン／脱泡用組成物混合物 | |
| WO2017130709A1 (ja) | 固形製剤、固形製剤の製造方法及び水素発生方法 | |
| AR013227A1 (es) | COMPOSICIoN GRANULAR DE SIMETICONA QUE FLUYE LIBREMENTE, FORMA DE DOSIFICACIoN ORAL SoLIDA FORMADA A PARTIR DE DICHA COMPOSICIoN Y PROCEDIMIENTO PARA PRODUCIR DICHA COMPOSICIoN | |
| KR20120112644A (ko) | 록소프로펜 함유 의약 조성물 | |
| JPH05500052A (ja) | 胃酸を結合する薬学的製剤 | |
| Mohamed et al. | Biocompatible supramolecular mesoporous silica nanoparticles as the next-generation drug delivery system | |
| JP2014019689A (ja) | 水素発生用粉末 | |
| Gomes et al. | Benefits and risks of clays and clay minerals to human health from ancestral to current times: a synoptic overview | |
| JP2015527321A5 (enExample) | ||
| JP2006528211A (ja) | 癌治療用の内服用の薬 | |
| JPS61275220A (ja) | 新規薬学的組成物 | |
| MD2722B2 (ro) | Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei | |
| JP2006528210A5 (enExample) | ||
| JP2006528210A (ja) | 岩粉、好適にはドロマイト岩粉をベースとした癌治療のための薬 | |
| AU2011304259A8 (en) | Antimicrobial and wound-healing action pharmaceutical composition for external application process of producing the same | |
| CA2227740C (en) | Gastrointestinal drug composition | |
| JP6125634B2 (ja) | 薬用粘土製剤 | |
| US9585913B2 (en) | Clay mineral for reducing inorganic phosphates, in particular in renal replacement therapy | |
| WO2006041843A3 (en) | Pharmaceutical dosage form comprising meloxicam | |
| JP6439503B2 (ja) | 固形製剤 | |
| CN102872019A (zh) | 一种采用微粉化技术的依非韦伦制剂 |